Franzč, Eleonora <br/><br/>
Interleukin-25 negatively controls pathogenic responses in the gut.  [electronic resource] 

 -  Inflammation & allergy drug targets  Jun 2011 
 - 187-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>2212-4055 
<br/><br/><label>Standard No.: </label>10.2174/187152811795564028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Colitis, Ulcerative--immunology<br/>Crohn Disease--immunology<br/>Feedback, Physiological<br/>Humans<br/>Immunity, Mucosal--drug effects<br/>Immunologic Factors--pharmacology<br/>Immunotherapy<br/>Interleukin-17--immunology<br/>Intestinal Mucosa--drug effects<br/>Th1-Th2 Balance--drug effects<br/>Th17 Cells--drug effects